Collage of CBMM pictures

Funded by The National Institute of Biomedical Imaging and Bioengineering

We design, manufacture, and deliver new tools to the biomedical community that utilize liquid biopsies for disease detection and management.

Our Vision & Mission


What is Precision Medicine?

The Precision Medicine initiative aims to shift away from a generic treatment approach to customizing medications for individuals. This tailored approach ensures that patients receive the most effective and safe treatments by targeting the specific characteristics of their illness. 

CBM² is contributing to the Precision Medicine initiative by developing advanced tools that can rapidly deliver crucial diagnostic and prognostic information, overcoming current testing limitations.

 

Metal compasses hover over a DNA model with red and blue spheres atop a grey cylindrical base.

Spread of images, diagrams, and text detailing tool development at the center

CBM² Tool Development for Precision Medicine

We are producing a suite of mixed-scale devices (i.e., task-specific modules) that can be integrated into a fluidic motherboard to produce systems, which can process liquid biopsy samples, for a broad range of clinical applications with a Precision Medicine focus. The attributes of our systems are:

•Devices made from thermoplastics via injection molding with mixed-scales structures (mm → nm)

•Extensive infrastructure for making and characterizing device architecture and material properties

•Ability to change the surface chemistry of the plastic to match the application (covalent attachment of biologics, alter surface wettability, etc.).

•Toolbox of devices for the selection of liquid biopsy markers from clinical samples (blood, saliva, urine, etc.)

•Label-free and single-molecule analysis device (X-ToF) for determining the molecular structure of biopolymers, such as DNA, RNA, and proteins.

•Modular systems with an automated workflow to accept a clinical sample, enrich the required liquid biopsy marker, and secure molecular information on even low abundant markers.

•Ability of integrated system to search of epigenetic, epitranscriptomic, and post-translational modifications in DNA, RNA, and proteins, respectively.


Our Resources

We have a variety of tools at our disposal, such as this TERA-Fab E-Series lithography tool. Our facilities allow researchers to design and fabricate microfluidic and nanofluidic devices in thermoplastics and perform highly efficient isolation and molecular analysis (CTCs, EVs, cfDNA).

CBM² Stories

A large screen displays the text "KU's workforce drives the economy by meeting regional needs" behind the tour group

Soper Group Hosts Tour at Gray-Little Hall During Economic Development Group Visit

As part of a larger KDOC Industry Engagement Visit, the Soper Group held a tour of the Gray-Little Hall cleanrooms and gave presentations on various research projects to an international delegation of consuls.
Lab assistant holds up computer chip in blue light.

University of Kansas drives $7.8 billion economic impact in Kansas, study shows

The University of Kansas is a powerful engine of economic growth and job creation for the state of Kansas, according to a new study detailing the university’s impact.
Steven A. Soper and Suresh Shivanka

Foundation Distinguished Professor Steven A. Soper named April 2025 Sutton Family Research Impact Award recipient

The Department of Chemistry congratulates Distinguished Professor Steven A. Soper on receiving the April 2025 Sutton Family Research Impact Award! ...

New Publications from CBM² Members, May 2025

Last month, two new articles were published from Dr. Andy Godwin concerning research on different types of breast cancer.

Upcoming Events

Organization Statistics

5
Partnering Organizations
4
Supporting Universities
40+
Researchers
Neon-colored interconnected bio-structures in elongated hexagonal patterns. Representing BioModular Multi-Scale Systems for Precision Medicine

Work with us

The Center is excited to accept requests for collaboration projects with researchers in the biomedical and microfluidics community.

Collaboration & Service Projects